MitchellS.ElkindMD

Spinal Disorder, Vascular Neurology

Columbia University

Dr. Elkind is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
710 W 168th St
New York, NY 10032
Phone+1 212-305-1710

Fax+1 212-305-1658

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1993 - 1996
Brigham and Women's HospitalInternship, Internal Medicine, 1992 - 1993
Harvard Medical SchoolClass of 1992

America's Top Doctors Castle Connolly, 2014
Top Doctors: New York Metro Area Castle Connolly, 2014
New York Magazine: Top Doctors Castle Connolly, 2013
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Super Doctor SuperDoctors.com
Join now to see all

PubMed

Other

Cryptogenic stroke
Elkind MS, Prabhakaran S
http://www.uptodate.com/contents/cryptogenic-stroke
UpToDate, Wolters Kluwer Health - 2012-10-25
Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction
Elkind MS, Gupta R
http://www.uptodate.com/contents/decompressive-hemicraniectomy-for-malignant-middle-cerebral-artery-
UpToDate, Wolters Kluwer Health - 2012-02-10

Inequities in Heart Health Found by Race, GenderFebruary 3rd, 2025
Long-Term Cognitive Monitoring Warranted After First StrokeOctober 11th, 2024
Anticoagulation Uncertainty in Embolic Stroke of Undetermined SourceSeptember 20th, 2024
Join now to see all

FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
Neurology Research Education And Mentorship ProgramNational Institute Of Neurological Disorders And Stroke2010–2012
Stroke Incidence And Risk Factors In A Tri-Ethnic RegionNational Institute Of Neurological Disorders And Stroke2008–2012
Neuroprotection With Statin Therapy For Acute Recovery Trial (NEUSTART)National Institute Of Neurological Disorders And Stroke2010–2011
Neuroprotection With Statin Therapy For Acute Stroke-Recovery TrialNational Institute Of Neurological Disorders And Stroke2007–2008
Levels Of Inflammatory Markers In Treatment Of StrokeNational Institute Of Neurological Disorders And Stroke2005–2008
Inflammatory And Infectious Burden And Risk Of StrokeNational Institute Of Neurological Disorders And Stroke2004–2008
Neuroprotection With Statin Therapy For Acute StrokeNational Institute Of Neurological Disorders And Stroke2004–2006
Inflammation And Infection As Risk Factors In StrokeNational Institute Of Neurological Disorders And Stroke2002–2006
Hu23f2g In Patients With Acute Ischemic StrokeNational Center For Research Resources2000–2002